Skip to main content

Spinal Cord Injury Cervical

1
Pipeline Programs
3
Companies
4
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
1
Water FaucetPhase 21 trial
Brain Computer InterfaceN/A1 trial
Active Trials
NCT07225582Recruiting3Est. Sep 2030
NCT07062796Completed25Est. Aug 2024
ONWARD Medical
ONWARD MedicalNetherlands - Eindhoven
1 program
Task Practice combined with Transcutaneous Spinal Cord StimulationN/A1 trial
Active Trials
NCT06494020Recruiting6Est. Oct 2027
Lineage Cell Therapeutics
1 program
OPC1PHASE_11 trial
Active Trials
NCT06841770Recruiting10Est. Jun 2037

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
2031
Human BioSciencesWater Faucet
Lineage Cell TherapeuticsOPC1
Human BioSciencesBrain Computer Interface
ONWARD MedicalTask Practice combined with Transcutaneous Spinal Cord Stimulation

Clinical Trials (4)

Total enrollment: 44 patients across 4 trials

NCT07062796Human BioSciencesWater Faucet

Access-H20: Sensor-driven Smart Faucet

Start: Jun 2024Est. completion: Aug 202425 patients
Phase 2Completed
NCT06841770Lineage Cell TherapeuticsOPC1

A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury

Start: Jun 2025Est. completion: Jun 203710 patients
Phase 1Recruiting
NCT07225582Human BioSciencesBrain Computer Interface

Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia

Start: Jan 2026Est. completion: Sep 20303 patients
N/ARecruiting
NCT06494020ONWARD MedicalTask Practice combined with Transcutaneous Spinal Cord Stimulation

Task Practice and Spinal Cord Stimulation

Start: Sep 2024Est. completion: Oct 20276 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 44 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.